C section News and Research

RSS

Herbalife declares fourth-quarter dividend

Herbalife Ltd. today reported that its board of directors approved a quarterly cash dividend of $0.20 per share to shareholders of record effective March 2, 2010, payable on March 16, 2010.

19 Feb 2010

Amerigroup's fourth-quarter revenues rise 18.5%

Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.

19 Feb 2010

Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN

Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.

19 Feb 2010

Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.

19 Feb 2010

Report examines how medical technology changes state of health care

Federal researchers Wednesday released a report that examines how medical technology is changing the state of health care.

19 Feb 2010

Universal American announces fourth-quarter and full-year 2009 financial results

Universal American Corp. today announced financial results for the quarter and year ended December 31, 2009.

19 Feb 2010

Anulex Technologies announces the commercial availability of Xclose Plus Tissue Repair System

Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal disc Preservation & Anular Repair™ products, announced the commercial availability of the Xclose™ Plus Tissue Repair System at the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves meeting in Orlando, Florida.

18 Feb 2010

Ventas reports 7.8% increase in normalized FFO for year ended December 31, 2009

Ventas, Inc. said today that normalized Funds From Operations (“FFO”) for the year ended December 31, 2009 increased 7.8 percent to $409.0 million, from $379.5 million for the comparable 2008 period.

18 Feb 2010

Phase 2 study results: VEGF Trap-Eye improves vision in patients with DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG announced that VEGF Trap-Eye showed positive results in a Phase 2 study in patients with diabetic macular edema (DME).

18 Feb 2010

Deaf and hard-of-hearing patients seeking treatment at OIP to receive interpreters for effective communication

Patients who are deaf or hard-of-hearing, who seek treatment at the Orthopedic Institute of Pennsylvania, will receive qualified interpreters when needed for effective communication as required by federal law under a Settlement Agreement reached with the U.S. Department of Health and Human Services.

18 Feb 2010

State-of-the-art review of stereological methods for lung morphometry

The ATS and the European Respiratory Society have issued official standards for the quantitative assessment of lung structure.

18 Feb 2010

Detroit home health agency owner pleads guilty over Medicare fraud

Detroit-area resident Muhammad Shahab pleaded guilty today for his role in organizing a Detroit-area home health care fraud scheme, announced Assistant Attorney General Lanny Breuer of the Criminal Division; U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office; and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services, Office of Inspector General's (HHS-OIG), Chicago Regional Office.

18 Feb 2010

RiskMetrics questions Novartis merger proposal

The Alcon Independent Director Committee (the “Committee”) of Alcon, Inc. today announced that RiskMetrics Group, Inc., a global leader in risk management, corporate governance and financial research and analysis, has raised concerns about the adequacy of the merger proposal by Novartis AG (“Novartis”) to Alcon’s minority shareholders and the legality of any attempt by Novartis to unilaterally impose a full takeover of Alcon.

18 Feb 2010

Olympus launches new medical devices for LESS surgery

A variety of new medical devices specifically designed for Laparo-Endoscopic Single-Site surgery (LESS surgery) has been announced and introduced by Olympus Europa Holding GmbH and Olympus Medical Systems Corporation. LESS surgery is an advanced, minimally invasive operation technique by which an endoscope and hand instruments are inserted through an access port anchored in just one small incision, usually made in the navel. After developing all the medical devices needed to perform LESS surgery, Olympus has yet again proven its leadership in the field. The release of these innovative devices in Europe took place in autumn 2009.

From Evident Corporation - Life Sciences 18 Feb 2010

Physicians of New York Walk In Medical Group open new center in New York City

The physicians of New York Walk In Medical Group, PC, are opening the doors today at the fifth "DR Walk-In Medical Center" in a Duane Reade Pharmacy in New York City. The "Doctor on Premises" center will open at 10:00 a.m. at the new Duane Reade at 17th Street and Eighth Avenue in the Chelsea section of Manhattan.

17 Feb 2010

SBi introduces 10-minute new surgical technique DVD for hand surgeons

Small Bone Innovations, Inc., a leading, privately-held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, is making available to hand surgeons a new 10-minute new surgical technique DVD showing an innovative volar approach to insertion of its SR™ PIP (Proximal Interphalangeal) implant.

17 Feb 2010

Fourth-quarter and full-year 2009 results announced by Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2009.

16 Feb 2010

International discussion held to find solutions for agricultural challenges of all time

An eminent panel of science and policy experts braved a historic blizzard today to identify solutions for the greatest agricultural challenges of all time. The global dialogue comes in response to a final call for action from the late Nobel Laureate, Dr. Norman Borlaug, to feed the world and improve the lives of farmers, all while preserving natural resources.

15 Feb 2010

Effective smoking cessation treatments

With the national trend toward quitting smoking flat, psychologists are finding some success with treatments aimed at helping smokers from underserved groups, including racial and ethnic minorities and those with psychiatric disorders.

15 Feb 2010

Hypnosis has potential therapeutic value in children with respiratory disorders

Hypnosis has potential therapeutic value in children with respiratory disorders for alleviating symptoms such as habit cough or unexplained sensations of difficulty breathing and for lessening a child's discomfort during medical procedures.

15 Feb 2010